Recent News

• 02.06.2025 - 60 Degrees Pharma Announces Closing of $1.075 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
• 02.05.2025 - 60 Degrees Pharma Announces $1.075 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
• 01.30.2025 - 60 Degrees Pharma Announces Closing of $1.043 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
• 01.29.2025 - 60 Degrees Pharma Announces $1.043 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Recent Filings

• 02.06.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 02.06.2025 - EX-99.1 EX-99.1
• 02.06.2025 - 8-K Current report
• 02.03.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors